Japan· JP-3136401A1184
ヒドロキソコバラミン酢酸塩
A hydroxocobalamin product containing ヒドロキソコバラミン酢酸塩, registered in Japan by 扶桑薬品工業, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Hydroxocobalamin is registered in 11 of 19 countries.
Countries holding a registration under ATC B03BA03 (hydroxocobalamin), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 6 of them publish a price we can compare per daily dose
Hydroxocobalamin · ATC B03BA03
11 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ヒドロキソコバラミン酢酸塩
- Manufacturer
- 扶桑薬品工業
- Country
- Japan (JP)
- ATC code
- B03BA03
- ATC class
- Hydroxocobalamin
- Defined daily dose
- 20 mcg, P
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
40 interactions on record for hydroxocobalamin.
Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hydroxocobalamin · interactions on record
40 records
- 2 moderate
- 38 info
Most severe, free to view
- ChloramphenicolJ01BA01moderate
- Arsenic trioxideL01XX27moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B03BA03
Hydroxocobalamin, as other registers publish it.
- United KingdomCobalin-H 1mg/1ml solution for injection ampoulesAdvanz Pharma
- FinlandCoheminOrion Corporation
- DenmarkCoheminOrion Corporation
- FinlandCohemin DepotOrion Corporation
- United StatesCyanokitBTG INTERNATIONAL INC.
- United KingdomCyanokit 2.5g powder for solution for infusion vialsSERB
- United KingdomCyanokit 2.5g powder for solution for infusion vialsImported (United States)
- United KingdomCyanokit 5g powder for solution for infusion vialsSERB
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ea834169-77f3-4ff6-b0e1-be4e1d09ada7 GET /v1/drugs/ea834169-77f3-4ff6-b0e1-be4e1d09ada7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１ｍｇ１管",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3136401A1184",
"category": "注射薬",
"price_yen": 63,
"generic_name": "ヒドロキソコバラミン酢酸塩",
"product_name_jp": null,
"therapeutic_class": "3136",
"transitional_expiry": null
}See everything about hydroxocobalamin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.